ClinicalTrials.Veeva

Menu

Effect of Expiratory Muscle Strength in Patients With Bronchiectasis

N

Nisanur Tutuş

Status

Enrolling

Conditions

Bronchiectasis

Study type

Observational

Funder types

Other

Identifiers

NCT07104942
bronchiectasis_expiratory

Details and patient eligibility

About

This study investigates the relationship between expiratory muscle strength and clinical outcomes such as disease severity, hospital admissions, and quality of life in individuals with bronchiectasis.

Full description

This study aims to examine the relationship between expiratory muscle strength and clinical outcomes such as disease severity, hospital admission history, and quality of life in individuals with bronchiectasis. Effective coughing is a critical physiological reflex for airway clearance; however, the relationship between expiratory muscle strength and cough effectiveness in the bronchiectasis population has not been clearly established. Identifying expiratory muscle weakness as a potential contributor to increased symptom burden and impaired airway clearance may improve clinical understanding and support the development of targeted physiotherapy interventions. The findings of this study could serve as a foundation for future interventional research in pulmonary rehabilitation and respiratory muscle training for this population.

Enrollment

64 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Having a diagnosis of non-cystic fibrosis bronchiectasis
  • Without an acute infection at the time of assessment (confirmed by medical history, serum C-reactive protein levels, chest X-ray and/or HRCT).
  • Being between 18 and 65 years of age

Exclusion criteria

  • Myopathies
  • Stroke (Cerebrovascular accident - CVA)
  • Pregnancy
  • Unstable cardiac disease

Trial contacts and locations

1

Loading...

Central trial contact

Nisanur Tutuş

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems